-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Initiates Coverage On Arrowhead Pharma with Buy Rating, Announces Price Target of $108

Benzinga·09/08/2026 16:04:34
Listen to the news
Citigroup analyst Eric Joseph initiates coverage on Arrowhead Pharma (NASDAQ:ARWR) with a Buy rating and announces Price Target of $108.